- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04230486
VR System for Cross-modal Rehabilitation of Hemianopia
November 4, 2022 updated by: Wake Forest University Health Sciences
Virtual Reality System for Cross-modal Rehabilitation of Hemianopia
The purpose of this research study is to investigate the effectiveness of a new rehabilitation for visual hemianopia.
The study team believes a cross-modal rehabilitation technique delivered by a virtual reality system can help restore the visual field for subjects with homonymous hemianopia.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study tests a novel rehabilitation system, translated from promising cross-modal rehabilitation animal research, that is the first treatment capable of restoring the visual field for hemianopia patients.
This noninvasive technique uses a virtual reality device to deliver visual and auditory stimulus.
The goals of this study are to obtain proof of concept and procure rehabilitation data to support the development of this novel rehabilitation treatment.
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27101
- Wake Forest School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult volunteers diagnosed with homonymous visual hemianopia / hemianopsia (ages 18-99)
Exclusion Criteria:
- Volunteers who are unable to complete the study tasks or understand instructions
- Subjects that are not able to provide written consent or verbal assent
- Subjects who are not available to complete all rehabilitation sessions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group Virtual Reality (VR) Treatment
Visual Auditory Virtual Reality rehabilitation for visual hemianopia
|
Subjects will put on a virtual reality rehabilitation system which will present sights and sounds.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Humphrey Visual Field Perimetry
Time Frame: Baseline
|
The area of the subject's visual field measured by 30-2 Humphrey visual field (HVF) perimetry.
Both left and right sides will be tested.
The deficit side includes is the hemianopic side.
The intact side is the non-hemianopic side.
During the HVF test, light is projected into a white bowl with a standardized background light intensity to form a circular stimulus, around 30 cm away from the patient's eye.
The overall field mapping technique used is a form of static perimetry, where a stimulus appears in various areas of the field of vision.
The patient indicates when they can see the stimulus and the perimetrist then records the point where the stimulus was seen.
These data points are used to determine the patient's visual field.
|
Baseline
|
|
Humphrey Visual Field Perimetry
Time Frame: up to 2 Months
|
The area of the subject's visual field measured by 30-2 Humphrey visual field (HVF) perimetry.
Both left and right sides will be tested.
The deficit side includes is the hemianopic side.
The intact side is the non-hemianopic side.
During the HVF test, light is projected into a white bowl with a standardized background light intensity to form a circular stimulus, around 30 cm away from the patient's eye.
The overall field mapping technique used is a form of static perimetry, where a stimulus appears in various areas of the field of vision.
The patient indicates when they can see the stimulus and the perimetrist then records the point where the stimulus was seen.
These data points are used to determine the patient's visual field.
|
up to 2 Months
|
|
Virtual Reality (VR) Visual Field Test--Mean Percent Correct
Time Frame: Day 1
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 1
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 2
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 2
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 3
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 3
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 4
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 4
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 5
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 5
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 6
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 6
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 7
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 7
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 8
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 8
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 9
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 9
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 10
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 10
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 11
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 11
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 12
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 12
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 13
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 13
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 14
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 14
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 15
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 15
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 16
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 16
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 17
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 17
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 18
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 18
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 19
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 19
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 20
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 20
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 21
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 21
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 22
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 22
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 23
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 23
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 24
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 24
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 25
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 25
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 26
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 26
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 27
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 27
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 28
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 28
|
|
Virtual Reality Visual Field Test--Mean Percent Correct
Time Frame: Day 29
|
Percent of correct trials in each location tested.
Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested.
Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress.
The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
|
Day 29
|
|
Peripheral Visual Field Frame Test
Time Frame: Baseline
|
The number of points subjects can detect in each location of the visual field along the horizontal meridian.
Percent of correct trials in each location tested in the deficit and intact side.
Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
|
Baseline
|
|
Peripheral Visual Field Frame Test
Time Frame: up to 2 Months
|
The number of points subjects can detect in each location of the visual field along the horizontal meridian.
Percent of correct trials in each location tested in the deficit and intact side.
Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
|
up to 2 Months
|
|
Peripheral Visual Field Frame Test
Time Frame: 3 Months
|
The number of points subjects can detect in each location of the visual field along the horizontal meridian.
Percent of correct trials in each location tested in the deficit and intact side.
Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
|
3 Months
|
|
Peripheral Visual Field Frame Test
Time Frame: 6 Months
|
The number of points subjects can detect in each location of the visual field along the horizontal meridian.
Percent of correct trials in each location tested in the deficit and intact side.
Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
|
6 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)--Composite Score
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
This score is calculated from the average of all subscale scores in the NEI VFQ-25 excluding the general health score.
The score ranges from 0 to 100.
A higher score denotes better vision-related quality of life.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Composite Score
Time Frame: 6 month
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
This score is calculated from the average of all subscale scores in the NEI VFQ-25 excluding the general health score.
The score ranges from 0 to 100.
A higher score denotes better vision-related quality of life.
|
6 month
|
|
NEI-VFQ-25--General Health Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The General Health Score is a subscale that measures the participant's self-report of their overall health.
The score ranges from 0 to 100.
A higher score denotes better perception of overall health.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--General Health Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The General Health Score is a subscale that measures the participant's self-report of their overall health.
The score ranges from 0 to 100.
A higher score denotes better perception of overall health.
|
6 months
|
|
NEI-VFQ-25--General Vision Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The General Vision Score measures the participant's reported quality of vision.
The score ranges from 0 to 100.
A higher score denotes a better perception of vision
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--General Vision Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The General Vision Score measures the participant's reported quality of vision.
The score ranges from 0 to 100.
A higher score denotes a better perception of vision
|
6 months
|
|
NEI-VFQ-25--Ocular Pain Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Ocular Pain Score Subscale measures reported pain or discomfort in and around the eyes.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to ocular pain.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Ocular Pain Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Ocular Pain Score Subscale measures reported pain or discomfort in and around the eyes.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to ocular pain.
|
6 months
|
|
NEI-VFQ-25--Near Activities Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Near Activities Score Subscale measures difficulty with performing near activities.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to near activities.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Near Activities Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Near Activities Score Subscale measures difficulty with performing near activities.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to near activities.
|
6 months
|
|
NEI-VFQ-25--Distance Activities Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Distance Activities Score Subscale measures difficulty with performing distance activities.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to distance activities.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Distance Activities Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Distance Activities Score Subscale measures difficulty with performing distance activities.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to distance activities.
|
6 months
|
|
NEI-VFQ-25--Social Functioning Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Social Functioning Score Subscale measures how vision difficulties affect social functioning.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to social functioning.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Social Functioning Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Social Functioning Score Subscale measures how vision difficulties affect social functioning.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to social functioning.
|
6 months
|
|
NEI-VFQ-25--Mental Health Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Mental Health Score Subscale measures how much patients feel vision affects their mental health.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life relating to mental health.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Mental Health Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Mental Health Score Subscale measures how much patients feel vision affects their mental health.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life relating to mental health.
|
6 months
|
|
NEI-VFQ-25--Role Difficulties Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Role Difficulties Score Subscale measures how limited by their vision patients feel they are.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life relating to role difficulties.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Role Difficulties Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Role Difficulties Score Subscale measures how limited by their vision patients feel they are.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life relating to role difficulties.
|
6 months
|
|
NEI-VFQ-25--Dependency Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Dependency Score Subscale measures how much patients are dependent on other people due to their vision.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to dependency.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Dependency Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Dependency Score Subscale measures how much patients are dependent on other people due to their vision.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to dependency.
|
6 months
|
|
NEI-VFQ-25--Driving Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Driving Score Subscale measures patients' reported difficulty with driving.
The score ranges from 0 to 100.
Patients who do not drive are not given a driving score.
A higher score denotes better vision-specific quality of life related to driving.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Driving Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Driving Score Subscale measures patients' reported difficulty with driving.
The score ranges from 0 to 100.
Patients who do not drive are not given a driving score.
A higher score denotes better vision-specific quality of life related to driving.
|
6 months
|
|
NEI-VFQ-25--Color Vision Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Color Vision Score Subscale measures how much difficulty patients have with using color vision to complete daily activities such as picking out clothes.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to color vision.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Color Vision Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Color Vision Score Subscale measures how much difficulty patients have with using color vision to complete daily activities such as picking out clothes.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to color vision.
|
6 months
|
|
NEI-VFQ-25--Peripheral Vision Score Subscale
Time Frame: Baseline, 2 months, 3 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Peripheral Vision Score Subscale measures how much difficulty patients have with their peripheral vision to complete daily activities.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to peripheral vision.
|
Baseline, 2 months, 3 months
|
|
NEI-VFQ-25--Peripheral Vision Score Subscale
Time Frame: 6 months
|
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision.
The Peripheral Vision Score Subscale measures how much difficulty patients have with their peripheral vision to complete daily activities.
The score ranges from 0 to 100.
A higher score denotes better vision-specific quality of life related to peripheral vision.
|
6 months
|
|
Veterans Affairs Low Vision Visual Function Questionnaire-48 (VA LV VFQ-48)--Item Score
Time Frame: Baseline, 2 months
|
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The acceptable range for the average item score is <= 2.34 (most difficult) and >=-2.22 (least difficult).
Scores out of this range indicate something other than visual impairment is governing the patient's responses.
The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity.
|
Baseline, 2 months
|
|
VA LV VFQ-48--Item Score
Time Frame: 3 months
|
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The acceptable range for the average item score is <= 2.34 (most difficult) and >=-2.22 (least difficult).
Scores out of this range indicate something other than visual impairment is governing the patient's responses.
The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity.
|
3 months
|
|
VA LV VFQ-48--Item Score
Time Frame: 6 months
|
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The acceptable range for the average item score is <= 2.34 (most difficult) and >=-2.22 (least difficult).
Scores out of this range indicate something other than visual impairment is governing the patient's responses.
The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity.
|
6 months
|
|
VA LV VFQ-48--Composite Score
Time Frame: Baseline, 2 months
|
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The acceptable range for the average item score is <= 2.34 and >=-2.22.
Scores out of this range indicate something other than visual impairment is governing the patient's responses.
The reading domain score is calculated by calculating the average score of reading items.
The composite score approximates a person's visual ability.
The score is calculated using Massof's algorithm using the inverse hyperbolic tangent equation.
For the composite score, a lower score is better.
|
Baseline, 2 months
|
|
VA LV VFQ-48--Composite Score
Time Frame: 3 months
|
he VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The acceptable range for the average item score is <= 2.34 and >=-2.22.
Scores out of this range indicate something other than visual impairment is governing the patient's responses.
The reading domain score is calculated by calculating the average score of reading items.
The composite score approximates a person's visual ability.
The score is calculated using Massof's algorithm using the inverse hyperbolic tangent equation.
For the composite score, a lower score is better.
|
3 months
|
|
VA LV VFQ-48--Composite Score
Time Frame: 6 months
|
he VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The acceptable range for the average item score is <= 2.34 and >=-2.22.
Scores out of this range indicate something other than visual impairment is governing the patient's responses.
The reading domain score is calculated by calculating the average score of reading items.
The composite score approximates a person's visual ability.
The score is calculated using Massof's algorithm using the inverse hyperbolic tangent equation.
For the composite score, a lower score is better.
|
6 months
|
|
VA LV VFQ-48--Reading Domain Score
Time Frame: Baseline, 2 months
|
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The reading domain score is calculated by calculating the average score of reading items.
Scores range from 0 to 3.5 logits, with higher scores denoting better ability to perform activities.
The Reading Domain Score is the average functional reserve of the items measuring the reading functional domain, excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
|
Baseline, 2 months
|
|
VA LV VFQ-48--Reading Domain Score
Time Frame: 3 months
|
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The reading domain score is calculated by calculating the average score of reading items.
Scores range from 0 to 3.5 logits, with higher scores denoting better ability to perform activities.
The Reading Domain Score is the average functional reserve of the items measuring the reading functional domain, excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
|
3 months
|
|
VA LV VFQ-48--Reading Domain Score
Time Frame: 6 months
|
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities.
The reading domain score is calculated by calculating the average score of reading items.
Scores range from 0 to 3.5 logits, with higher scores denoting better ability to perform activities.
The Reading Domain Score is the average functional reserve of the items measuring the reading functional domain, excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Grating Acuity Test
Time Frame: First visit after the completion of rehabilitation (1 or 2 months)
|
Change in the percentage of correctly identified trials.
|
First visit after the completion of rehabilitation (1 or 2 months)
|
|
Color Vision Test
Time Frame: First visit after the completion of rehabilitation (1 or 2 months)
|
Change in the percentage of correctly identified trials for each color.
|
First visit after the completion of rehabilitation (1 or 2 months)
|
|
Shape Recognition Test
Time Frame: First visit after the completion of rehabilitation (1 or 2 months)
|
Change in the percentage of correctly identified trials.
|
First visit after the completion of rehabilitation (1 or 2 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Huai Jiang, PhD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 29, 2020
Primary Completion (Actual)
July 30, 2021
Study Completion (Actual)
July 30, 2021
Study Registration Dates
First Submitted
January 14, 2020
First Submitted That Met QC Criteria
January 14, 2020
First Posted (Actual)
January 18, 2020
Study Record Updates
Last Update Posted (Actual)
November 30, 2022
Last Update Submitted That Met QC Criteria
November 4, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00061542
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
All of the individual participant data that underlie the results reported in the publication will be shared after deidentification (text, tables, figures, and appendices)
IPD Sharing Time Frame
Data will be made available immediately following publication for five years.
IPD Sharing Access Criteria
Anyone who wishes to access the data for any purpose.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemianopia, Homonymous
-
Alexandra BowersNational Eye Institute (NEI); Chadwick Optical Inc.CompletedHomonymous HemianopiaUnited States, United Kingdom
-
Massachusetts Eye and Ear InfirmaryNational Eye Institute (NEI)Active, not recruiting
-
Massachusetts Eye and Ear InfirmaryNational Eye Institute (NEI)Active, not recruitingHomonymous Hemianopia | Homonymous QuadrantanopiaUnited States
-
Institute of Child HealthEnrolling by invitation
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruitingStroke | Hemianopia | Homonymous Hemianopia | Cortical BlindnessFrance
-
University of RochesterRochester Institute of TechnologyRecruitingStroke, Ischemic | Stroke Hemorrhagic | Hemianopia, Homonymous | Visual Field Defect, Peripheral | Hemianopsia | Hemianopia | Quadrantanopia | Occipital Lobe Infarct | Hemianopsia, Homonymous | Vision Loss Partial | QuadrantanopsiaUnited States
-
University of RochesterNational Eye Institute (NEI)CompletedStroke, Ischemic | Hemianopia | Quadrantanopia | Vision Loss Partial | Hemianopia HomonymousUnited States
-
Wake Forest University Health SciencesNot yet recruitingHemianopia, Homonymous | Cortical Blindness, Unspecified Side of BrainUnited States
-
Massachusetts Eye and Ear InfirmaryNational Eye Institute (NEI)RecruitingHemianopia, Homonymous | Tunnel Vision | Visual Field Defect, Peripheral | Visual Field Constriction Bilateral | Visual Field Defect Homonymous BilateralUnited States
-
University Hospital TuebingenMerck Sharp & Dohme LLCCompleted
Clinical Trials on Cross-model Visual Auditory Rehabilitation
-
National Council of Scientific and Technical Research...Completed
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyUnknown
-
Northwestern UniversityCompletedCognitive Impairment | Hearing Loss, SensorineuralUnited States
-
University of ValenciaCompleted
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)Recruiting
-
Superior UniversityRecruitingParkinson DiseasePakistan
-
New York UniversityThe New York Eye & Ear InfirmaryCompletedHearing Loss, Sensorineural | Vestibular DisorderUnited States
-
Necmettin Erbakan UniversityCompleted
-
University of British ColumbiaCompletedHearing Loss, FunctionalCanada
-
National Yang Ming UniversityNot yet recruitingStroke Syndrome